VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 223 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $248,729 | -24.4% | 27,947 | -14.0% | 0.00% | 0.0% |
Q1 2024 | $329,144 | -7.8% | 32,492 | -8.4% | 0.00% | -50.0% |
Q4 2023 | $356,949 | +10.2% | 35,482 | +2.7% | 0.00% | 0.0% |
Q3 2023 | $323,846 | +29287.1% | 34,562 | -17.8% | 0.00% | -77.8% |
Q4 2022 | $1,102 | -99.9% | 42,035 | -23.0% | 0.01% | -10.0% |
Q3 2022 | $1,186,000 | -32.5% | 54,570 | -9.0% | 0.01% | -28.6% |
Q2 2022 | $1,757,000 | – | 59,975 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |